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1. Introduction 29 
Affective Instability (AI) is a transdiagnostic symptom (Broome et al., 2015b; Henry et al., 30 
2001b). It has been defined as rapid oscillations of intense affect, with difficulty regulating 31 
these or their behavioural consequences (Marwaha, 2013). Multiple strands of evidence have 32 
associated AI with suicidal thinking (Palmier-Claus et al., 2012; Yen et al., 2004), health 33 
service use (Marwaha et al., 2013c), new onset of depression (Marwaha et al., 2015), 34 
psychotic symptoms (Marwaha et al., 2013a), onset of bipolar disorder and increasing time to 35 
recovery (Howes et al., 2011; Stange et al., 2016). It is also independently linked to greater 36 
medication use and detention under mental health legislation (Patel et al., 2015). It is 37 
associated with childhood trauma experiences (including abuse) and it is suggested that it 38 
may partly explain the connection between these and psychiatric disorders (Aas et al., 2016; 39 
Marwaha et al., 2016; Moffa et al., 2017). The estimated prevalence of AI in the general 40 
population is 14%, with levels being higher in younger people and women (Marwaha et al., 41 
2013c; Patel et al., 2015). We (Broome et al., 2015a), and others (Harrison et al., 2017) have 42 
suggested that trans-diagnostic investigation of AI is compatible with the NIMH Research 43 
Domain Criteria project (Insel, 2014), a framework for understanding mental disorders by 44 
study of dysfunction in individual psychological and biological systems. 45 
 46 
Through systematically reviewing the literature we have previously identified AI as 47 
having three core affect components: intensity, lability, and ability to control the oscillations 48 
or their behavioural consequences  (Marwaha et al., 2014). The review also identified that 49 
comprehensive measurement of all three components is rarely undertaken. The current 50 
literature is limited in part by theoretical and methodological heterogeneity in how AI is 51 
understood and assessed. This means that studies of AI in different diagnostic groups cannot 52 
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be compared, and hence understanding whether AI is similar in different disorders and how it 53 
contributes to outcomes such as functioning are hard to ascertain. As such, there is a 54 
significant gap in understanding this clinical phenomenon. A second major shortcoming of 55 
the current literature is that nearly all studies to date, apart from a few notable exceptions 56 
(Ben-Zeev and Young, 2010; Ben-Zeev et al., 2009), have lacked comparisons with 57 
individuals without mental disorder. This means it is unclear how far AI represents 58 
psychopathology needing intervention or indeed whether it is a core aspect of abnormal 59 
mental states, or is a feature of normal mental life. 60 
 61 
To our knowledge, only three studies to date have compared AI in different diagnostic 62 
groups using the same assessment procedures but limiting assessment of AI to two if its 63 
domains. Henry et al. (2001a) examined AI using the Affect Lability Scale (ALS) and Affect 64 
Intensity Measure (AIM) in out-patients with Borderline Personality Disorder (BPD) (N=29), 65 
bipolar disorder: type II without BPD (N=14), BPD and bipolar disorder: type II (N=12), and 66 
no BPD or bipolar disorder but other personality disorders (N=93). Lability scores were 67 
significantly (p< 0.05) higher in BPD, whilst bipolar patients tended (p=0.06) to have higher 68 
lability scores than other personality disorders. No differences in affect intensity were 69 
observed.  70 
 71 
In a similar study those with bipolar disorder had significantly higher scores on the 72 
euthymia-elation subscale of the ALS as well as significantly higher scores on affect 73 
intensity, whereas those with BPD experienced more shifts between anxiety-depression, 74 
euthymia-anger and significantly fewer shifts between euthymia-elation and depression-75 
elation (Reich et al., 2012). Most recently Richard-Lepouriel et al (Richard-Lepouriel et al., 76 
2016) compared ALS and AIM scores in people with bipolar disorder, attention deficit 77 
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hyperactivity disorder (ADHD) and controls (dentistry students and doctors). Those with 78 
ADHD and bipolar disorder scored higher on ALS than controls, with AIM scores being 79 
highest for ADHD. Whilst affective lability appears to be higher in BPD, and people with 80 
bipolar disorder, results for affective intensity are discrepant between studies with some 81 
evidence that affective intensity may be higher in people with mental disorders than in 82 
controls. 83 
 84 
Given the paucity of previous research, we aimed to expand the diagnostic groups in 85 
which AI is examined (given the suggestion that AI is transdiagnostic), compare these 86 
“cases” with psychologically “healthy controls”, assess AI more comprehensively, and test 87 
whether AI is independently linked to functioning within a clinical population. 88 
 89 
2. Aims 90 
 91 
We aimed to answer the following research questions: 92 
 93 
1. Does affective instability differ between clinical cases and controls and between 94 
diagnostic groups? 95 
2. To what extent are measures of affective lability, intensity and ability to control affect 96 
correlated in a trans-diagnostic clinical sample? 97 
3. Is affective instability associated with functioning in a clinical population independent 98 
of diagnosis? 99 
3. Methods 100 
We undertook a case-control study among users of secondary care mental health services 101 
(cases) and primary care attenders without evidence of current mental disorder (controls). 102 
Ethical approval was obtained from the Coventry and Warwickshire Ethics Committee, UK. 103 
 5 
Participant consent and data collection was completed by an experienced researcher with a 104 
psychology background. 105 
 106 
3.1 Participants 107 
 108 
Individuals with a range of diagnoses were recruited from secondary care mental 109 
health services within Coventry and Warwickshire, UK through convenience sampling. The 110 
aim was to include individuals who were representative of the ‘typical’ case mix of these 111 
services, so participants were recruited in out-patient departments, day hospitals, community 112 
mental health teams and a specialist personality disorder service. Inclusion criteria were: a] 113 
aged 18-65 years; b] capacity to give informed consent; c] the primary reason for attending 114 
the mental health service was for management of a clinical diagnosis of BPD, bipolar 115 
affective disorder, major depressive episode (moderate or severe depressive episode) or non-116 
affective psychosis as reported by a Consultant Psychiatrist. The researcher confirmed the 117 
diagnosis with the Psychiatrist using ICD-10 criteria. 118 
 119 
Exclusion criteria were: a] an acute illness episode (sufficient to require urgent or 120 
inpatient care) according to the patient’s Consultant Psychiatrist; b] unable or unwilling to 121 
complete the assessments (e.g. individuals with a clinically assessed learning disability, with 122 
insufficient command of the English language to understand and complete questionnaires); or 123 
c] individuals with a primary ICD-10 diagnosis of dependency to drugs or alcohol (to avoid 124 
confounding by drug or alcohol misuse). 125 
 126 
Control participants were recruited from primary care (general practitioner surgeries). 127 
Physicians asked patients if they were interested, a researcher in the waiting room then 128 
consented the patients and completed the battery of questionnaires.  Exclusion criteria for the 129 
control group were: a] presence of a current mental disorder (including common mental 130 
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disorders such as depression or anxiety disorders); b] dependency on substances or alcohol; 131 
c] previous diagnosis of BPD, bipolar disorder, or non-affective psychosis, according to their 132 
primary care records.   133 
 134 
3.2 Materials 135 
 136 
Details were collected on participants’ diagnosis (for cases) and confirmed by their 137 
Consultant Psychiatrist. Details on duration of illness (cases only) and current medications 138 
were identified by a researcher, from clinical records. Medications were grouped as anti-139 
psychotic, anti-depressant, anti-anxiety, mood stabiliser, anti-depressant/mood-stabiliser or 140 
‘other’ (medication not directly related to the patient’s psychiatric diagnosis). 141 
Sociodemographic information was collected on age (years), gender, marital status 142 
(married/cohabiting, single, separated/widowed), employment (employed, unemployed, 143 
other), ethnicity (White British, other), and highest education level (None/GCSE, A Level, 144 
Degree/higher degree) (see Table 1).  145 
 146 
3.3 Assessment scales 147 
 148 
Participants were asked to complete four questionnaires relating to affective / mood 149 
instability.  150 
1. The Affective Lability Scale - short form (ALS-18) (Harvey et al., 1989), is a 151 
reliable and valid measure comprising 18 items coded 0-3. Overall score is 152 
obtained by taking the mean of the scores for each item as indicated by the scale 153 
developers. Three subscales can be derived; ‘anxiety-depression’, ‘depression-154 
elation’, and ‘anger’.  155 
2. The Affective Intensity Measure-20 (AIM) (Larsen et al., 1986a) was used to 156 
measure affect intensity. The AIM contains 20 items coded 1 to 6. A person’s 157 
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overall score is obtained by taking the mean of the scores for each item. The AIM 158 
has good internal consistency, test-retest reliability and construct validity (Larsen 159 
et al., 1986b).  160 
3. The Affective Control Scale (ACS) (Williams et al., 1997) comprises 42 items, 161 
coded 1 to 7 (with some items requiring reverse scoring); it has good 162 
psychometric properties including construct validity. A higher ACS score 163 
indicates reduced ability to control affect. Four subscales can be derived; ‘anger’, 164 
‘positive affect’, ‘depressed mood’, and ‘anxiety’.  165 
4. Mood fluctuation rate: Because of the lack of a previously well validated scale for 166 
fluctuation rate (Marwaha, 2013) we used a new bespoke schedule for this study. 167 
Mood fluctuation rate was assessed using a question from the Structured Clinical 168 
Interview for DSM Disorders (SCID). It asks the respondent to state how often 169 
they experienced a sudden marked shift in mood. Study participants rated the 170 
number of significant mood fluctuations they experienced over a week. 171 
Respondents were asked to consider this for each one of the weeks in the last 172 
month prior to assessment, and possible responses were 0, 1-3, 4-7, or >7 mood 173 
changes over each week.  174 
 175 
Functioning was measured using the WHO Disability Assessment Schedule 2.0 – 12 176 
item version (WHODAS; (Üstün, 2010). This contains 12 items each coded 0 to 4. To obtain 177 
a person’s final score, the simple version entails summing the scores from each of the 12 178 
items, scores range from 0-48. For consistency in comparing with the other scores above, the 179 
mean rather than the sum was used in the current study.  180 
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 181 
3.4 Data analysis 182 
 183 
Descriptive statistics including means/medians with standard deviations/interquartile ranges, 184 
or frequencies with percentages where relevant, were used to investigate participant 185 
demographics and characteristics of AI in the different diagnostic groups and controls.  There 186 
are no clear rules about the acceptable fraction of missing data to justify imputation. As such, 187 
we decided on 10%, as a level that would allow imputation, thus enabling us to use as much 188 
of the data as possible, whilst also retaining reliability and accuracy (Steyerberg, 2008). As 189 
such scores were imputed if the patient had less than 10% missing items. This translates as: 190 
AIM: Up to 2 missing values, ALS-18: Up to 2 missing values, ACS: Up to 4 missing values, 191 
WHODAS: 1 missing value. 192 
 193 
Two sample t-tests were used to compare means between the cases and controls after 194 
verifying that relevant assumptions were valid. Proportions were compared using chi-squared 195 
tests. General linear models (GLMs) were used to compare the mean lability (ALS), intensity 196 
(AIM), and subjective ability to control affect (ACS) outputs across cases (different 197 
diagnostic groups) and the control group. Adjustment was made for age, sex and educational 198 
level if necessary. Model assumptions were checked and, in the case of an overall significant 199 
difference in mean score across the diagnosis groups, pairwise post-hoc comparisons of 200 
adjusted mean scores were performed with a Bonferroni correction. To investigate how far 201 
the different aspects of affective instability correlate with each other, the linear association 202 
between each pair of measurement scales for the full sample and for the cases only was 203 
assessed using Pearson’s product moment correlation. Association between each 204 
measurement scale and the mood fluctuation rate was assessed using Spearman’s rank 205 
correlation. 206 
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 207 
Multiple regression was used to examine the association between affective instability 208 
and general assessment of functioning as measured by the WHODAS (Üstün, 2010) in 209 
clinical cases, adjusting for diagnosis and other patient characteristics. A purposeful selection 210 
approach was used to fit the model. Manual backward elimination was first used to remove 211 
variables based on Wald statistics using p = 0.05 as the cut-point for removal. Removed 212 
variables were then re-entered into the model one-by-one to check their significance. 213 
Variables initially considered in the model included: (a) socio-demographics: age, sex, 214 
ethnicity, education level, marital status, (employment status was not considered in the model 215 
since the WHODAS incorporates this parameter in ratings), (b) illness characteristics: 216 
diagnosis, duration of illness, total number of medications, (c) AI measures: mood fluctuation 217 
rate and the mean scores for the ACS, ALS-18 and AIM. All analyses were conducted in 218 
IBM SPSS Statistics 24.  219 
 220 
4. Results 221 
 222 
4.1 Participant characteristics 223 
 224 
The initial dataset comprised 101 participants, but 9 individuals were excluded due to 225 
missing data (3 bipolar, 2 major depression, and 2 controls). Hence the final sample (N=94) 226 
comprised of 69 cases and 25 controls. 227 
      228 
Table 1 describes the socio-demographic characteristics of included participants by 229 
group (case versus control), and diagnostic subgroups (bipolar disorder (n=11), BPD (n=12), 230 
psychosis (n=21), and major depression (n=25)). There was a significant difference between 231 
cases and controls in mean age (p=0.001), employment status (p=0.001) and marital status 232 
(p<0.001). Age was controlled for during regression analysis as AI is influenced by this 233 
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(Marwaha et al., 2013b). Duration of illness was recorded in the dataset for 67 out of the 69 234 
cases and was positively skewed with the sample having been ill for a median duration of 36 235 
months (interquartile range (IQR) 15-156 months). Across the diagnostic groups, participants 236 
with depression reported the longest duration of illness (median 120 months, IQR 12-258), 237 
followed by participants with BPD (median 36 months, IQR 24-120), psychosis (median 27 238 
months, IQR 20.5-111), and bipolar disorder (median 24 months, IQR 9-36), respectively. 239 
    240 
Table 1 about here 241 
 242 
The commonest class of medication prescribed was anti-depressants, and most patients 243 
reported being prescribed one (25%) or two (25%) medications. Seventeen percent of cases 244 
(N=12) were not taking any medication. We did not explore, type of medications and their 245 
impact on our results because of the lack of a robust typology of the effectiveness of 246 
medications indicated for affective instability (Lieb et al., 2010). 247 
 248 
4.2 Comparison of questionnaire scores between cases and controls 249 
Differences in the unadjusted mean scores between cases and the controls for all 250 
measures are presented in Table 2. Age and sex were found not to be significant across the 251 
sample in the general linear model (GLM) for the ACS, AIM, and WHODAS scores; whilst 252 
there was trend towards significance for the effect of age on ALS score (P = 0.068).  253 
 254 
Table 2 about here 255 
 256 
Affect lability (ALS): When adjusted for age, a statistically overall significant 257 
difference was observed in mean ALS-18 scores between cases and controls (F (4,88) = 258 
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7.195, p < 0.001). Post-hoc pairwise comparisons of mean scores revealed significantly lower 259 
mean ALS-18 scores for the control group compared to each diagnosis group but no 260 
significant differences between diagnoses.  261 
 262 
Affect intensity (AIM): There was little difference in the mean AIM scores between 263 
groups, with slightly higher mean scores found for controls compared to cases. These 264 
differences were not statistically significant (p = 0.867).  265 
 266 
Ability to control affect (ACS): An overall significant difference was found between 267 
mean ACS scores across the different diagnostic groups, including controls (F (4,89) = 268 
14.520, p < 0.001). Post-hoc pairwise comparisons of the mean scores revealed significantly 269 
higher mean ACS scores (meaning lower control) for each diagnostic group compared to 270 
controls (p < 0.05). A significant difference was also found between the mean scores in 271 
borderline personality disorder patients and patients with non-affective psychosis (p = 0.010). 272 
 273 
Mood fluctuations in the last week: Table 2 shows the number of participants (i.e. 274 
frequency with percentage) who reported each number of mood fluctuations over the past 275 
week prior to assessment. This revealed that cases tended to have more changes in their mood 276 
state than controls, although no overall differences were found in rate of mood fluctuation 277 
between groups (p=0.310). Those with major depression reported the greatest number of 278 
mood fluctuations in the last week, followed by non-affective psychosis, borderline 279 
personality disorder and then bipolar disorder.  280 
 281 
4.3 Correlations between different components of AI, mood fluctuation rate and functioning 282 
 12 
Correlations are shown in table 3. Strong positive correlations were found between 283 
the ALS and the ACS in the full and cases only analysis. Weak to moderate correlations were 284 
found between the AIM and the ALS. When assessing the association between each 285 
measurement scale and mood fluctuation rate ‘last week’, moderate to strong positive 286 
correlations were found between mood fluctuation and ALS and ACS. There was a weak 287 
correlation between AIM and mood fluctuation rate. All correlations were weaker when 288 
focusing on the cases only. 289 
 290 
Table 3 about here 291 
 292 
4.4 AI and functioning 293 
 294 
 In the clinical sample, an overall significant difference was observed between mean 295 
WHODAS scores across the different diagnosis groups, F (4,89) = 11.454, p < 0.001 (p < 296 
0.05 for bipolar disorder). Post-hoc pairwise comparisons revealed significantly lower mean 297 
WHODAS scores for the control group compared to each diagnosis group, as might be 298 
expected, but differences between diagnostic groups were not significant. 299 
 300 
A multiple regression model investigating factors associated with the WHODAS 301 
score, demonstrated that both ALS-18 and ACS scores were significantly associated with 302 
current level of functioning. After correcting for multicollinearity, ALS-18 score was retained 303 
in the final model (beta=0.845, p<0.001), along with the total number of medications 304 
(beta=0.107, p<0.046). All other variables considered, including diagnosis, were not 305 
significantly associated with WHODAS score in the final model. 306 
 307 
5. Discussion 308 
 309 
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5.1 Main findings 310 
 311 
This is the first study, to our knowledge, that has comprehensively assessed the core 312 
components of affective instability in a trans-diagnostic clinical population and compared 313 
clinical cases with a control group without mental disorder. We found only affective lability 314 
and affective control is significantly different in people with a range of mental disorders in 315 
comparison to those without. No differences were observed between people with and without 316 
mental disorder in the intensity of affect experienced or the rate of mood fluctuation in the 317 
last week. Two of the three components of affective instability (lability and intensity) did not 318 
differ significantly between individuals with different psychiatric diagnoses, although ability 319 
to control affect was significantly different in individuals with BPD in comparison to non-320 
affective psychosis. Whilst the small numbers within each diagnostic group mean that 321 
interpretation can only be exploratory, contrary to expectation, we found that the greatest 322 
number of mood changes in a week was experienced by people with major depression, 323 
followed by non-affective psychosis, BPD and then bipolar disorder. 324 
 325 
 In terms of the affective instability construct, the strongest inter-correlation was found 326 
between lability and ability to control affect, with much weaker (modest) correlations 327 
between affective intensity and ability to control affect (or lability and control). Finally, only 328 
affective lability, but not affective intensity, ability to control affect or mood fluctuation rate 329 
was associated within functioning independent of diagnosis and other important confounders. 330 
 331 
 5.2 Limitations 332 
 333 
Our sample size was relatively modest (just under 100). This limited the statistical 334 
power of our analyses and increased the risk that our results might be due to type II error. 335 
This means that comparisons of affective instability between diagnostic groups in particular, 336 
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should be considered entirely exploratory, and other interpretations tentative. Another caveat 337 
to comparisons between diagnoses is that we did not complete inter-rater reliability 338 
assessments. However, this is the largest study to date exploring our questions.  339 
 340 
Our observations related to affective instability are limited to the four mental 341 
disorders that we sampled. We cannot therefore generalize our findings to other disorders, 342 
where affective instability is known to be important such as OCD (Bowen et al., 2015) or 343 
ADHD (Asherson et al., 2007). Furthermore, we could not take into account the contribution 344 
made by mental or physical comorbidities in our sample. However, given our sample of cases 345 
were those in contact with secondary mental health services there are likely to be high levels 346 
of comorbidity. Therefore, it is possible that high levels of affective lability and problems 347 
with affective control are linked to comorbidity and this should be the focus of future studies. 348 
In our regression modelling we were not able to control for some factors known to impact 349 
functioning such as cognition, illness severity, premorbid functioning and depressive 350 
symptoms. 351 
 352 
The cases sampled were not in an acute illness episode and it is conceivable that this 353 
biased estimate of group difference towards the null, that is, there is no difference between 354 
the cases and controls on affective instability measures. Affect intensity (and possibly 355 
instability) might vary with illness acuity, which might explain why differences between 356 
cases and controls in the present study were smaller than those reported in an in-patient 357 
sample (Henry et al., 2008; Reich et al., 2012).  Whilst we did not assess illness severity, we 358 
adjusted for illness duration and number of medications, both of which might be expected to 359 
be associated with illness severity. More specifically, we also did not assess current mood 360 
state using standardised measures and therefore do not know how far the severity of current 361 
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mood (e.g depth of depression) could have impacted on our results. There is little current 362 
evidence on how far AI changes, as mood becomes lower or more elated to guide how this 363 
could have influenced out main findings. Indeed, in bipolar disorder, AI is found in both 364 
euthymic and periods of acute illness (Harvey, 2008). We explored whether AI is different 365 
between cases and controls. Future studies should also aim to explain the differences between 366 
affective instability in people with mental disorders and without. 367 
 368 
We used assessment measures which require recall of affective experiences. These 369 
may be prone to bias, particularly when compared to ecological momentary assessments 370 
(EMA) (Broome et al., 2015b). How accurately people with mental disorders recall their 371 
affective experiences might differ depending on diagnosis. The ratings themselves at an 372 
individual level may also be dependent on an initial calibration to understand what is meant 373 
by a “marked” shift in mood (Holmes et al., 2016). Therefore, paradoxically individuals with 374 
fewer mood fluctuations may better report retrospective fluctuations as they would have 375 
stood out in their experience, whilst those with more frequent fluctuations may only report 376 
“marked” ones, as small fluctuations were perhaps normalised by their experience. This is 377 
one potential explanation of why depressed patients reported more fluctuations than other 378 
groups, though this was not statistically significant. The question used to assess mood 379 
fluctuation didn’t specify type of affect and therefore could have excluded swings in anger 380 
and irritability, which have been shown to differentiate between diagnosis (Tsanas et al., 381 
2016). We also recognise that current mood state may have impacted on assessment.  382 
 383 
Whilst momentary assessment of psychopathology appears feasible using 384 
smartphones (Tsanas et al., 2016), it is as yet unclear whether retrospective affective 385 
assessments and EMA relate to the same underlying psychological or biological processes, 386 
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especially as the former will be subject to important cognitive processes (e.g contextual 387 
processing), which control how mood is experienced (Dubad et al., 2018). There is also the 388 
issue of how far individuals recognize and name affective states in the same way.  389 
 390 
5.3 Theoretical and clinical implications 391 
 392 
 393 
Our findings only partly validated our original definition of affective instability as a 394 
trans-diagnostic parameter incorporating affect lability, ability to control and intensity 395 
(Marwaha et al., 2014). Affect lability and the ability to control these were indeed found to 396 
occur at higher levels than in controls and at similar levels across the different diagnostic 397 
groups. Scores on both measures were also relatively strongly correlated with each other re-398 
enforcing the notion that they are facets of the same or similar underlying latent construct. 399 
Affective intensity was only relatively weakly associated with other affective instability 400 
measures. Replication in a much larger sample is required to understand how far this pattern 401 
holds true. In the current study affective intensity was no different between cases and controls 402 
or between the cases themselves consistent with previous literature (Henry et al., 2001b). 403 
Whilst caution is necessary in interpretation, this does suggest that intensity of affect may not 404 
be a feature that may help delineate the boundaries of “normal” or “abnormal” affective 405 
experience, or at least in the way that it was measured here. Again, a study with a larger 406 
sample size is required. 407 
 408 
Mood fluctuation rate (as measured by our bespoke instrument) showed some 409 
concurrent validity with two measures of affective instability, and surprisingly, fluctuation 410 
rate was no different between cases and controls. This may be a function of our sample size, 411 
but this finding should prompt larger studies, with more comprehensive fluctuation change 412 
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assessments to investigate this area. Crucially, these studies need to include people without 413 
mental disorders as controls. 414 
 415 
We used a comprehensive way to measure affective instability in people with 416 
different diagnoses and the current results as well as previous research provides some 417 
counterbalance to the notion that affective instability is specific to or more severe in people 418 
with bipolar disorder or borderline personality disorder. The challenge now is to understand 419 
whether more subtle differences exist that may be clinically useful, such as whether a 420 
particular valence change is more or less common in different disorders (Reich et al., 2012) 421 
or whether richer, digitally captured mood data is helpful in differentiating disorders. Current 422 
evidence indicates clinicians do not use diagnostic criteria effectively to distinguish disorders 423 
such as BPD and bipolar disorder in which affective instability symptoms are seen to overlap 424 
(Saunders et al., 2015). Further research into common and uncommon valence changes in the 425 
disorders, perhaps incorporating digital mood monitoring, may help to resolve this clinical 426 
difficulty. 427 
 428 
Finally, we demonstrate that affective instability independently adversely impacts 429 
functioning in people with mental disorders, and this is independent of diagnosis. The 430 
measure of functioning that we used suggests the impact could be on multiple domains 431 
including learning new tasks, joining in community activities, day to day work and 432 
maintaining friendships. We have previously found that interpersonal conflict is part of the 433 
pathway from affective instability and incident depression (Marwaha et al., 2015) and the 434 
current study is also consistent with other work highlighting the impact of affective instability 435 
on functioning in bipolar and transdiagnostically (Patel et al., 2015; Strejilevich et al., 2013). 436 
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We extend these previous findings by identifying that affective lability, as opposed to other 437 
aspects of AI such as ability to control affect or intensity, has the greatest impact.  438 
 439 
As such affective lability has the potential for being a therapeutic target that could 440 
improve functional outcomes in mental disorders. Pharmacological interventions that are 441 
widely used (e.g mood stabilising antipsychotics) and emotional regulation training (Berking 442 
et al., 2008) need more robust trial evidence, but could have a significant impact on distress 443 
and outcomes. 444 
  445 
 446 
 447 
 448 
 449 
 450 
 451 
 452 
 453 
 454 
 455 
 456 
 457 
 458 
 459 
 460 
 461 
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Table 1: Descriptive statistics by group; case versus control and diagnosis subgroups (n = 94) 
Characteristic 
Control 
(n = 25) 
Case 
(n = 69) 
Cases by diagnosis 
Total 
(n = 94) 
 
 
 Case versus control Bipolar 
(n = 11) 
Borderline 
(n = 12) 
Psychosis 
(n = 21) 
Depression 
(n = 25)  P value Test 
Age (years); mean (SD) 48.5 (10.8) 
38.2 
(12.8) 
35.6 
(13.3) 33.9 (11.0) 34.9 (9.8) 44.2 (14.1) 
41.0 
(13.1) 0.001 t test 
Male; n (%) 9 (36.0%) 36 (52.2%) 6 (54.5%) 2 (16.7%) 
12 
(57.1%) 16 (64.0%) 
45 
(47.9%) 0.165 Chi square test 
Employment; n (%):        
0.001 
Chi Square test 
(employed vs 
unemployed, n = 
90) 
- Employed 19 
(76.0%) 
26 
(37.7%) 5 (45.5%) 4 (33.3%) 6 (28.6%) 11 (44.0%) 
45 
(47.9%) 
- Unemployed 5 (20.0%) 40 (58.0%) 6 (54.5%) 8 (66.7%) 
14 
(66.7%) 12 (48.0%) 
45 
(47.9%) 
- Other 1 (4.0%) 3 (4.3%) 0 (0.0%) 0 (0.0%) 1 (4.8%) 2 (8.0%) 4 (4.3%) 
Ethnicity; n (%)        
0.259 
Chi square test 
- White British 18 
(72.0%) 
57 
(82.6%) 9 (81.8%) 10 (83.3%) 
14 
(66.7%) 24 (96.0%) 
75 
(79.8%) 
- Other 7 (28.0%) 12 (17.4%) 2 (18.2%) 2 (16.7%) 7 (33.3%) 1 (4.0%) 
19 
(20.2%) 
Education; n (%)        
0.061 
Chi square test 
(n = 89) - None/GCSE 7 (28.0%) 35 (50.7%) 5 (45.5%) 5 (41.7%) 
12 
(57.1%) 13 (52.0%) 
42 
(44.7%) 
- A level 3 (12.0%) 16 (23.2%) 4(36.4%) 2 (16.7%) 5 (23.8%) 5 (20.0%) 
19 
(20.2%) 
- Degree/higher degree 11 
(44.0%) 
17 
(24.6%) 2 (18.2%) 5 (41.7%) 3 (14.3%) 7 (28.0%) 
28 
(29.8%) 
- [Missing] 4 (16.0%) 1 (1.4%) - - 1 (4.8%) - 5 (5.3%) 
 24 
Marital status; n (%)        
< 0.001 
Chi square test 
 - Married/cohabiting 20 
(80.0%) 
22 
(31.9%)  1 (9.1%) 6 (50.0%) 5 (23.8%) 10 (40.0%) 
42 
(44.7%) 
- Single/separated/ 
widowed 5 (20.0%) 
47 
(68.1%) 
10 
(90.9%) 6 (50.0%) 
16 
(76.2%) 15 (60.0%) 
52 
(55.3%) 
 25 
Table 2: Unadjusted mean scores (with standard deviation) and count (%) for each measurement scale and subscales 
 
Measurement scale 
Controls 
(n = 25) 
Cases (n = 69) 
All 
(n = 94) 
Case versus 
control 
(General linear 
models, F test) 
Bipolar 
(n = 11) 
Borderline 
(n = 12) 
Psychosis 
(n = 21) 
Depression 
(n = 25) 
ACS (scale 1-7) 3.36 (0.56) 4.39 (0.66) 5.14 (0.58) 4.23 (0.86) 4.52 (0.86) 4.21 (0.92) p<0.001 
 ACS: Anger 3.06 (0.60) 4.31 (0.83) 5.21 (0.96) 4.07 (0.89) 4.08 (1.15) 3.97 (1.11)  
 ACS: Positive-affect 3.48 (0.63) 4.17 (0.73) 4.12 (1.02) 4.05 (0.89) 3.87 (1.03) 3.88 (0.89)  
 ACS: Depressed 3.36 (0.75) 4.96 (0.88) 5.92 (0.72) 4.40 (1.01) 5.38 (1.04) 4.64 (1.27)  
 ACS: Anxiety 3.42 (0.57) 4.31 (0.84) 5.63 (0.60) 4.42 (1.23) 4.93 (0.95) 4.43 (1.13)  
ALS-18 (scale 0-3) 0.64 (0.58) 1.47 (0.62) 1.66 (0.49) 1.53 (0.67) 1.50 (0.62) 1.29 (0.71) p<0.0011 
 ALS-18: 
Anxiety/Depression 
0.55 (0.65) 1.49 (0.69) 2.23 (0.79) 1.60 (1.01) 1.88 (0.87) 1.46 (1.00)  
 ALS-18: Depression/Elation 0.86 (0.70) 1.66 (0.57) 1.45 (0.58) 1.65 (0.73) 1.52 (0.53) 1.38 (0.70)  
 ALS-18: Anger 0.38 (0.48) 1.16 (0.95) 1.42 (0.96) 1.27 (0.88) 1.08 (1.03) 0.99 (0.92)  
AIM (scale 1-6) 3.50 (0.48) 3.45 (0.37) 3.37 (0.44) 3.42 (0.56) 3.37 (0.39) 3.42 (0.45) p=0.867 
Number of mood fluctuations 
reported in the last week 
      P=0.310 
0 
1-3 
4-7 
>7 
13 (52%) 
10 (40%) 
2 (8%) 
0 (0%) 
2 (18.2%) 
5 (45.5%) 
3 (27.3%) 
1 (9.1%) 
0 (0%) 
3 (25%) 
7 (58.3%) 
2 (16.7%) 
5(23.8%) 
4 (19%) 
7 (33.3%) 
5 (23.8%) 
2 (8%) 
8 (32%) 
7 (28%) 
8 (32%) 
22 (23.4%) 
30 (31.9%) 
26 (27.7%) 
16 (17.0%) 
 
WHODAS2 (scale 0-4) 0.54 (0.11) 1.43 (0.61) 1.83 (0.69) 1.75 (1.00) 1.89 (0.91) 1.44 (0.96) p<0.001 
 
 
                                               
1 Adjusted for age. 
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Table 3: Correlation coefficients between each pair of measurement scales 
 
Full -sample (N=94) 
  AIM ALS-18 ACS 
Mood fluctuation 
(last week) 
AIM  1 0.210 0.188 0.12 
ALS-18   1 0.776 0.61 
ACS    1 0.53 
Mood 
fluctuation 
(last week) 
 
   
1 
      
Cases only (N=69) 
  AIM ALS-18 ACS 
Mood fluctuation 
(last week) 
AIM  1 0.322 0.265 0.157 
ALS-18   1 0.666 0.45 
ACS    1 0.29 
Mood 
fluctuation 
(last week) 
 
   
1 
 
